This analysis indicates that proposed Medicaid reforms would have far-reaching consequences beyond federal budget savings, including negative health outcomes, economic losses, and health care system ...

The FDA has approved once-monthly dosing of Elrexfio (elranatamab-bcmm) for certain patients with relapsed or refractory multiple myeloma.

The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health care workers alike.

Our study highlights a concerning 3-fold increase in obesity-related cancer deaths since 1999,” said study author Faizan Ahmed, MD.

Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

Thousands of workers at federal health agencies lost their jobs this week after a US Supreme Court ruling cleared the way for the Trump administration to move forward with major staffing cuts.

Soon, many patients might initiate contact with the health system not by speaking with a call center worker or receptionist, but with AI.

Adjuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.

Childhood cancer survivors have a higher risk of developing severe COVID-19 than the general population, according to research published in The Lancet Regional Health: Europe.

Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.

The US Food and Drug Administration (FDA) has granted priority review to TAR-200 for the treatment of patients with Bacillus Calmette-Guérin (BCG)-unresponsive, high-risk non-muscle invasive bladder ...

Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.